Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
GSK1940029 is a stearoyl-CoA desaturase (SCD) inhibitor.1 It increases palmitate-induced phosphorylation of p70 ribosomal S6 kinase 1 (p70S6K1) and lactate dehydrogenase (LDH) release from AML12 hepatocytes when used at a concentration of 20 µM.2 GSK1940029 (10 µM) also increases palmitate-induced increases in extracellular and intracellular triglyceride levels in AML12 hepatocytes, an effect that can be reversed by the mammalian target of rapamycin (mTOR) inhibitor torin 1 (Item No. 10997).
WARNING This product is not for human or veterinary use.
1. 1,2,3-
2. mTORC1-